English
Back
Open Account
牛牛名人追蹤
wrote a column · Jan 6 14:30

Tracking Cathie Wood: Added nearly 230,000 shares of AI healthcare stock TEM, sold Roku and Shopify

On Monday Eastern Time, major U.S. stock indices closed higher across the board, driven by strong gains in financial stocks, with the Dow Jones Index hitting a record high. Next, market focus will shift to the U.S. non-farm payroll report released on Friday, which could have a significant impact on the Federal Reserve’s monetary policy path for 2026.
Against this backdrop, ARK Fund under Cathie Wood ‘didn’t chase the energy trend’ — heavily adding AI healthcare and autonomous driving while reducing e-commerce and streaming holdings, fully tying the portfolio to the 'innovation essential' sector.
On Monday Eastern Time, major U.S. equity indices closed higher across the board, driven by a strong rally in financial stocks, with the Dow Jones Industrial Average hitting a record high. Next, market focus will shift to the U.S. non-farm payroll report released on Friday, which may have significant implications for the Fed's monetary policy path in 2026. Against this backdrop, Cathie Wood’s ARK Fund “did not chase energy hotspots” — heavily adding AI healthcare and autonomous driving while simultaneously reducing holdings in e-commerce and streaming media, fully tying the portfolio to the "innovation essential" track. Direction of increased positions: AI application is the core Cathie Wood’s recent purchases were highly concentrated, almost all pointing to the same direction — AI healthcare and intelligent driving. 1. $Tempus AI (TEM.US)$ : Added nearly 230,000 shares,Tempus AI, as a representative of applying artificial intelligence to precision medicine, has been a key focus for ARK recently. It seems Cathie Wood is betting that 2026 will be the year AI shifts from 'selling shovels' (hardware) to 'using shovels' (applications). 2. $Tempus AI (TEM.US)$ : Added over 50,000 shares,Further strengthening the position in logistics autonomous driving. 3. $Personalis (PSNL.US)$ : Added nearly 50,000 shares,This is a company focused on precision oncology genetic testing. Its core technology is ultra-sensitive 'liquid biopsy' (detecting residual cancer cells through blood tests), which can...
Direction of increased position: AI application is the core
Cathie Wood's recent buy list has been highly concentrated, almost entirely pointing towards one direction — AI healthcare and intelligent driving.
1. $Tempus AI (TEM.US)$ : Added nearly 230,000 shares,Tempus AI, as a representative of applying artificial intelligence to precision medicine, has remained a key focus for ARK recently. It seems Cathie Wood is betting that 2026 will be the year AI transitions from 'selling shovels' (hardware) to 'using shovels' (applications).
2. $Tempus AI (TEM.US)$ : Increased position by more than 50,000 shares,Further strengthening its position in logistics autonomous driving.
3. $Personalis (PSNL.US)$ : Added nearly 50,000 shares,This is a company specializing in precision oncology genetic testing. Its core technology is ultra-sensitive 'liquid biopsy' (detecting residual cancer cells through blood tests), which can identify cancer recurrence earlier than traditional CT scans. Additionally, it possesses a vast amount of genetic data and is a key partner of Moderna in developing cancer vaccines, marking it as a high-potential stock in the 'AI + biomedicine' sector.
Direction of reduction: Saying goodbye to past favorites?
Compared to the decisiveness of buying, selling appears somewhat 'ruthless.' Former heavy-weight stocks are now being reduced.
1. $Roku Inc (ROKU.US)$ : Reduced nearly 110,000 shares,This used to be ARK's favorite streaming media stock. With uncertainties in the advertising market and intensifying competition in streaming services, ARK seems to be withdrawing funds from these 'older tech' names to chase AI targets with higher growth potential.
2. $Shopify (SHOP.US)$ : Reduced over 20,000 shares,This may primarily reflect portfolio balancing.
3. $Guardant Health (GH.US)$ and $Natera (NTRA.US)$ were both slightly reduced,Similarly in healthcare, ARK sold traditional liquid biopsy companies (GH/NTRA) while buying into TEM, emphasizing AI properties. Does this indicate she believes 'AI integration' will be the key driver of valuation for healthcare stocks moving forward?
Futubull's [Opportunities Page] has launched tracking for celebrity portfolio opportunities! Choose from multiple celebrity portfolios, follow the masters' strategies with one click, precisely lock onto high-quality targets, and invest with greater confidence!
On Monday Eastern Time, major U.S. equity indices closed higher across the board, driven by a strong rally in financial stocks, with the Dow Jones Industrial Average hitting a record high. Next, market focus will shift to the U.S. non-farm payroll report released on Friday, which may have significant implications for the Fed's monetary policy path in 2026. Against this backdrop, Cathie Wood’s ARK Fund “did not chase energy hotspots” — heavily adding AI healthcare and autonomous driving while simultaneously reducing holdings in e-commerce and streaming media, fully tying the portfolio to the "innovation essential" track. Direction of increased positions: AI application is the core Cathie Wood’s recent purchases were highly concentrated, almost all pointing to the same direction — AI healthcare and intelligent driving. 1. $Tempus AI (TEM.US)$ : Added nearly 230,000 shares,Tempus AI, as a representative of applying artificial intelligence to precision medicine, has been a key focus for ARK recently. It seems Cathie Wood is betting that 2026 will be the year AI shifts from 'selling shovels' (hardware) to 'using shovels' (applications). 2. $Tempus AI (TEM.US)$ : Added over 50,000 shares,Further strengthening the position in logistics autonomous driving. 3. $Personalis (PSNL.US)$ : Added nearly 50,000 shares,This is a company focused on precision oncology genetic testing. Its core technology is ultra-sensitive 'liquid biopsy' (detecting residual cancer cells through blood tests), which can...
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
7
237K Views
Report
Comments (3)
Write a Comment...
3
7
54